INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2008

Soy isoflavone supplementation was linked to slower PSA rise in recurrent prostate cancer.

In an open-label, nonrandomized phase II trial, 20 patients with prostate-specific antigen recurrence after previous local therapy consumed soy milk containing 47 mg of isoflavones three times daily for 12 months. An estimated annual PSA increase of 56% before entry slowed to 20% during the trial (p = 0.05). Post-entry slope was significantly reduced in 6 patients, increased in 2 patients, and remained statistically unchanged in 12 patients.

Study type
Open-label nonrandomized phase II trial
Who was studied
20 patients with rising PSA after prior local therapy
What was measured
Prostate-specific antigen slope and isoflavone levels

THE PAPER

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.

Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. BMC Cancer, 2008.

PubMed 18471323 ↗DOI 10.1186/1471-2407-8-132 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.